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Reply to ‘‘Reducing
Nonanastomotic Biliary
Strictures in Donation
After Circulatory Death
Liver Transplantation:
Cold Ischemia Matters’’
To the Editor:
We highly appreciate the interest and thecomments expressed in the letter by
Gilbo et al1 concerning our recent comparison
of hypothermic oxygenated perfused versus
unperfused human donated after circulatory
death (DCD) livers. We have shown in this
study that applying 1 to 2 hours Hypothermic
Oxygenated PErfusion (HOPE) after initial
cold storage protected extended DCD livers,
with improved graft function and without
intrahepatic cholangiopathy (IC).2 Cold ische-
mia in our HOPE-treated DCD livers was,
however, below 5hours in most cases, and
also 3 hours less compared with unperfused
DCD livers, due to local procurement of per-
fused DCD grafts (median 188minutes). The
question seemed, therefore, whether the
observed beneficial effect of HOPE was more
related to the difference in cold ischemia, than
to a true effect of HOPE.
Whereas only prospective randomized
studies will provide a final answer on the
benefit of machine perfusion techniques,
we believe, for several reasons, that HOPE
treatment was responsible for the observed
effects:
First, graft survival in our study was
significantly affected by HOPE treatment
(P ¼ 0.02), whereas it was independent from
the length of cold ischemia (P ¼ 0.5) in our
regression analysis. The hazard ratios (HRs)
for HOPE were 4.19 [95% confidence inter-
val (CI) 0.96–18.2], and for cold ischemia
1.0 (95% CI 0.84–1.43).
Secondly, IC in unperfused DCD
livers did not correlate with the length of
cold ischemia, for example, none of the
grafts, exposed to more than 8 hours cold
ischemia, suffered from IC (Fig. 1A).
Third, several experimental transplant
studies have shown a strong protective effect
by end-ischemic HOPE, compared with cold
storage alone, with identical cold ischemia in
both groups.3–5
We agree with Monbaliu et al1 that
cold ischemia should be reduced as much as
possible in DCD livers, as for any marginal
graft. However, reliable thresholds for cold
ischemia, related to irreversible IC, remain
difficult to determine. Available recommen-
dations differ between 6 and 9 hours,6–8
depending on additional risk factors, for
example, recipient LabMELD, donor age,
warm ischemia during implantation, or
previous liver transplantation. Most centers
try to keep cold ischemia in DCD liver
transplant below 8 hours. Accordingly,
recent data from the United Kingdom show,
in a large series of 187 DCD liver grafts, a
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FIGURE 1. A, Negative correlation of cold preservation and ischemic cholangiopathy in unperfused DCD grafts. B, Cold and warm
ischemia time in 40 machine-perfused human DCD livers (2012–2016).
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low incidence of IC (9.1%), despite a mean
cold ischemia of 7.3 hours, providing that
functional donor warm ischemia was kept
short (mean 20minutes).9 These results cor-
relate with another DCD series reporting
only 2.5% IC in 167 DCD livers, exposed
to a mean of 7 hours cold storage, together
with functional warm ischemia of less than
20minutes (mean 16minutes).10 In contrast,
an increase in the asystolic to cross-clamp
duration above 9minutes is associated with a
severe increase in the odds for the develop-
ment of IC or hepatic necrosis by 16% per
minute.11 Based on this, it is rather unlikely
that the very low incidence of IC in our
HOPE-treated patients is related to short
cold storage, in the presence of an extended
donor warm ischemia (asystolic to cross-
clamp duration 18minutes).2
We have meanwhile performed 40
DCD liver perfusions with HOPE, with a
median cold ischemia time of 210minutes
before HOPE, and a total cold preservation
time (including HOPE) of 328minutes
(Fig. 1B). Several grafts have been exposed
to longer cold ischemia with no obvious
disadvantage. Functional warm ischemia
and asystolic warm ischemia remain high
in our center (median 31 and 19minutes;
Fig. 1B), due to our legal restriction request-
ing long no-touch periods and additional
brain death confirmation after cardiac arrest.
Despite this burden, we currently do not see
IC in our HOPE-treated DCD livers, which
supports, from our point of view, a clear
advantage of this simple, practical, and
end-ischemic perfusion approach.
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